Bladder Carcinoma in Situ

Bladder Carcinoma in Situ, also known as carcinoma in situ of bladder, is related to bladder cancer and transitional cell carcinoma. An important gene associated with Bladder Carcinoma in Situ is MIR139 (MicroRNA 139), and among its related pathways/superpathways is Keratan sulfate biosynthesis. The drugs Paclitaxel and Hyaluronic acid have been mentioned in the context of this disorder. Affiliated tissues include lymph node and prostate.